Literature DB >> 17070723

Platelet-derived growth factor receptor-alpha is a key determinant of smooth muscle alpha-actin filaments in bone marrow-derived mesenchymal stem cells.

Stephen G Ball1, C Adrian Shuttleworth, Cay M Kielty.   

Abstract

Smooth muscle alpha-actin filaments are a defining feature of mesenchymal stem cells, and of mesenchyme-derived contractile smooth muscle cells, pericytes and myofibroblasts. Here, we show that adult bone marrow-derived mesenchymal stem cells express abundant cell surface platelet-derived growth factor receptor-alpha, having a high ratio to platelet-derived growth factor receptor-beta. Signaling through platelet-derived growth factor receptor-alpha increases smooth muscle alpha-actin filaments by activating RhoA, which results in Rho-associated kinase (ROCK)-dependent cofilin phosphorylation, enhancing smooth muscle alpha-actin filament polymerization, and also upregulates smooth muscle alpha-actin expression. In contrast, platelet-derived growth factor receptor-beta signaling strongly upregulates RhoE, which inhibits ROCK activity, promoting smooth muscle alpha-actin filament depolymerization. This study thus provides new insights into the distinct roles of platelet-derived growth factor receptor-alpha and -beta signaling in regulating the adult mesenchymal stem cell contractile cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17070723     DOI: 10.1016/j.biocel.2006.09.005

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  24 in total

Review 1.  Pathophysiological Functions of Rnd3/RhoE.

Authors:  Wei Jie; Kelsey C Andrade; Xi Lin; Xiangsheng Yang; Xiaojing Yue; Jiang Chang
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

2.  Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle.

Authors:  Akiyoshi Uezumi; So-ichiro Fukada; Naoki Yamamoto; Shin'ichi Takeda; Kunihiro Tsuchida
Journal:  Nat Cell Biol       Date:  2010-01-17       Impact factor: 28.824

3.  Synthetic osteogenic growth peptide promotes differentiation of human bone marrow mesenchymal stem cells to osteoblasts via RhoA/ROCK pathway.

Authors:  Zixian Chen; Xiaofeng Wang; Yunchao Shao; Deyuan Shi; Tongyi Chen; Dafu Cui; Xiaoxing Jiang
Journal:  Mol Cell Biochem       Date:  2011-07-08       Impact factor: 3.396

Review 4.  Mesenchymal stem cell subpopulations: phenotype, property and therapeutic potential.

Authors:  Miaohua Mo; Shan Wang; Ying Zhou; Hong Li; Yaojiong Wu
Journal:  Cell Mol Life Sci       Date:  2016-05-03       Impact factor: 9.261

5.  Mesenchymal stem cells are sensitive to treatment with kinase inhibitors and ionizing radiation.

Authors:  Nils H Nicolay; Eva Sommer; Ramon Lopez Perez; Ute Wirkner; Tilman Bostel; Anthony D Ho; Michael Lahn; Jürgen Debus; Rainer Saffrich; Peter E Huber
Journal:  Strahlenther Onkol       Date:  2014-05-27       Impact factor: 3.621

Review 6.  Vascular stem/progenitor cells: functions and signaling pathways.

Authors:  Weisi Lu; Xuri Li
Journal:  Cell Mol Life Sci       Date:  2017-09-27       Impact factor: 9.261

7.  Integral role of platelet-derived growth factor in mediating transforming growth factor-β1-dependent mesenchymal stem cell stiffening.

Authors:  Deepraj Ghosh; Loukia Lili; Daniel J McGrail; Lilya V Matyunina; John F McDonald; Michelle R Dawson
Journal:  Stem Cells Dev       Date:  2013-11-08       Impact factor: 3.272

8.  An essential role for fibronectin extra type III domain A in pulmonary fibrosis.

Authors:  Andrés F Muro; Federico A Moretti; Bethany B Moore; Mei Yan; Rachelle G Atrasz; Carol A Wilke; Kevin R Flaherty; Fernando J Martinez; Jessica L Tsui; Dean Sheppard; Francisco E Baralle; Galen B Toews; Eric S White
Journal:  Am J Respir Crit Care Med       Date:  2007-12-20       Impact factor: 21.405

9.  Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts.

Authors:  Charlotte Anderberg; Hong Li; Linda Fredriksson; Johanna Andrae; Christer Betsholtz; Xuri Li; Ulf Eriksson; Kristian Pietras
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

10.  Mesp1 coordinately regulates cardiovascular fate restriction and epithelial-mesenchymal transition in differentiating ESCs.

Authors:  R Coleman Lindsley; Jennifer G Gill; Theresa L Murphy; Ellen M Langer; Mi Cai; Mona Mashayekhi; Wei Wang; Noriko Niwa; Jeanne M Nerbonne; Michael Kyba; Kenneth M Murphy
Journal:  Cell Stem Cell       Date:  2008-07-03       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.